0001209191-20-048037.txt : 20200901 0001209191-20-048037.hdr.sgml : 20200901 20200824120326 ACCESSION NUMBER: 0001209191-20-048037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200819 FILED AS OF DATE: 20200821 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abney Michael Donald Jr. CENTRAL INDEX KEY: 0001631320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 201125863 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-19 0 0000353569 QUIDEL CORP /DE/ QDEL 0001631320 Abney Michael Donald Jr. 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 SVP - Distribution Common Stock 2020-08-19 4 M 0 2335 21.08 A 8969 D Common Stock 2020-08-19 4 M 0 3275 46.41 A 12244 D Common Stock 2020-08-19 4 S 0 5610 250.00 D 6634 D Common Stock 2020-08-20 4 M 0 1251 21.08 A 7885 D Common Stock 2020-08-20 4 M 0 1331 46.41 A 9216 D Common Stock 2020-08-20 4 S 0 2582 250.00 D 6634 D Non-Qualified Stock Options 21.08 2020-08-19 4 M 0 2335 0.00 D 2027-02-15 Common Stock 2335 4836 D Non-Qualified Stock Options 46.41 2020-08-19 4 M 0 3275 0.00 D 2028-01-16 Common Stock 3275 5937 D Non-Qualified Stock Options 21.08 2020-08-20 4 M 0 1251 0.00 D 2027-02-15 Common Stock 1251 3585 D Non-Qualified Stock Options 46.41 2020-08-20 4 M 0 1331 0.00 D 2018-01-16 Common Stock 1331 4606 D 7,172 shares vested on the second anniversary date of the grant date, February 15, 2019. 3,586 shares vested on the third anniversary date of the grant date, February 15, 2020. 3,585 shares will vest on the fourth anniversary date of the grant date. 4,606 shares vested on the second anniversary date of the grant date, January 16, 2020. 2,303 shares will vest on the third anniversary date of the grant date, January 16, 2021. 2,303 shares will vest on the fourth anniversary date of the grant date, January 17, 2022. All transactions reported herein were effected pursuant to a pre-established 10b5-1 trading plan. Robert J. Bujarski, attorney-in-fact for Michael D. Abney Jr. 2020-08-21